Keywords: fda, approves, campath, single, agent, b-cll, bayer

FDA approves Campath as single agent for B-CLL

Article | 01 October 2007

Print This

Bayer Schering Pharma, the pharmaceutical arm of Germany's Bayer AG, and US biotechnology major Genzyme say that the Food and ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in